| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |